Keros Therapeutics, Inc. (KROS) Total assets 2019–2025
Keros Therapeutics, Inc. (KROS) total assets at each fiscal year-end, per SEC filings.
$338.0MFY2025 · since FY2019: $11.0M → $338.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $338.0M | -45.1% |
| FY2024 | $615.9M | +66.4% |
| FY2023 | $370.0M | +20.6% |
| FY2022 | $306.8M | +20.2% |
| FY2021 | $255.3M | -5.3% |
| FY2020 | $269.4M | +2359.5% |
| FY2019 | $11.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KROS financial trends
KROS RevenueKROS Net incomeKROS Net marginKROS Gross profitKROS Gross marginKROS Operating incomeKROS Operating marginKROS Operating cash flowKROS Free cash flowKROS Capital expendituresKROS Return on equityKROS Stock buybacksKROS Dividends paidKROS Total liabilitiesKROS Shareholders’ equityKROS overview →